0000899243-15-007138.txt : 20151026
0000899243-15-007138.hdr.sgml : 20151026
20151026190351
ACCESSION NUMBER: 0000899243-15-007138
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151022
FILED AS OF DATE: 20151026
DATE AS OF CHANGE: 20151026
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC.
DATE OF NAME CHANGE: 20070427
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DENNER ALEXANDER J
CENTRAL INDEX KEY: 0001361754
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 151175962
MAIL ADDRESS:
STREET 1: C/O SARISSA CAPITAL MANAGEMENT LP
STREET 2: 660 STEAMBOAT ROAD, 3RD FLOOR
CITY: GREENWICH
STATE: CT
ZIP: 06830
FORMER NAME:
FORMER CONFORMED NAME: Denner Alexander J
DATE OF NAME CHANGE: 20060504
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-22
0
0000875045
BIOGEN INC.
BIIB
0001361754
DENNER ALEXANDER J
BIOGEN INC.
225 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2015-10-22
4
P
0
210000
277.80
A
210000
I
See Footnotes
Common Stock
2015-10-23
4
P
0
100000
276.77
A
310000
I
See Footnotes
Common Stock
7890
D
On October 22, 2015, each of Sarissa Capital Domestic Fund LP, a Delaware limited partnership ("Sarissa Domestic") and Sarissa Capital Offshore Master Fund LP, a Cayman Islands exempted limited partnership ("Sarissa Offshore"), purchased an aggregate of 128,806 and 81,194 shares, respectively, of common stock of Biogen Inc.
On October 23, 2015, each of Sarissa Domestic and Sarissa Offshore purchased an aggregate of 61,336 and 38,664 shares, respectively, of common stock of Biogen Inc.
Sarissa Capital Management GP LLC, a Delaware limited liability company ("Sarissa Capital GP"), is the general partner of Sarissa Capital Management LP, a Delaware limited partnership ("Sarissa Capital"), the investment advisor to the Sarissa Funds. Alexander Denner is the Chief Investment Officer of Sarissa Capital and the managing member of Sarissa Capital GP. By virtue of the foregoing, Dr. Denner may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) the shares that the Sarissa Funds directly beneficially own.
Dr. Denner disclaims beneficial ownership of the shares being reported on this Form 4 except to the extent of his pecuniary interest therein.
Matthew S. Gilman, Attorney in Fact for Alexander J. Denner
2015-10-26